| Paul S Kellerman, MD | |
|
3535 W 13 Mile Rd Ste 248, Beaumont Chronic Disease Management Clinic, Royal Oak, MI 48073-6770 | |
| (248) 551-1515 | |
| (248) 551-1516 |
| Full Name | Paul S Kellerman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 3535 W 13 Mile Rd Ste 248, Royal Oak, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497721401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 4301046818 (Michigan) | Primary |
| 207RN0300X | Internal Medicine - Nephrology | 45019 (Wisconsin) | Secondary |
| Entity Name | William Beaumont Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083833875 PECOS PAC ID: 9335051093 Enrollment ID: O20031104000279 |
News Archive
In a Comment published alongside The Lancet Series on sport and exercise medicine, Rod Jaques of the Faculty of Sport and Exercise Medicine UK, and Mike Loosemore of University College London, UK, highlight the lack of specialised training in sports medicine in undergraduate medical training.
Simply wearing a mask may not be enough to prevent the spread of COVID-19 without social distancing.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.
› Verified 8 days ago
| Entity Name | Beaumont Medical Group- Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
In a Comment published alongside The Lancet Series on sport and exercise medicine, Rod Jaques of the Faculty of Sport and Exercise Medicine UK, and Mike Loosemore of University College London, UK, highlight the lack of specialised training in sports medicine in undergraduate medical training.
Simply wearing a mask may not be enough to prevent the spread of COVID-19 without social distancing.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul S Kellerman, MD 130 Town Center Dr Ste 203, Beaumont Medical Staff Affairs, Troy, MI 48084-1744 Ph: () - | Paul S Kellerman, MD 3535 W 13 Mile Rd Ste 248, Beaumont Chronic Disease Management Clinic, Royal Oak, MI 48073-6770 Ph: (248) 551-1515 |
News Archive
In a Comment published alongside The Lancet Series on sport and exercise medicine, Rod Jaques of the Faculty of Sport and Exercise Medicine UK, and Mike Loosemore of University College London, UK, highlight the lack of specialised training in sports medicine in undergraduate medical training.
Simply wearing a mask may not be enough to prevent the spread of COVID-19 without social distancing.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.
› Verified 8 days ago
Nicole Marijanovich, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 Fax: 248-898-0580 | |
Vinayata Manuballa Kareti, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 661-948-0803 | |
Filip Ionescu, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Christopher Carpenter, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3535 W 13 Mile Rd Ste 605, Royal Oak, MI 48073 Phone: 248-551-0495 | |
Dr. Matthew Burns Cotant, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3577 W 13 Mile Rd, Suite 404, Royal Oak, MI 48073 Phone: 248-551-6900 Fax: 248-551-6909 | |
Geoffrey Prysak, MD, MPH Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 | |
Taylor Schoenheit, Nephrology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 |